| Efficacy and safety of meropenem–clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB S De Lorenzo, JW Alffenaar, G Sotgiu, R Centis, L D'Ambrosio, S Tiberi, ... European Respiratory Journal 41 (6), 1386-1392, 2013 | 209 | 2013 |
| Simultaneous determination of rifampicin, clarithromycin and their metabolites in dried blood spots using LC–MS/MS DH Vu, RA Koster, MS Bolhuis, B Greijdanus, RV Altena, DH Nguyen, ... Talanta 121, 9-17, 2014 | 101 | 2014 |
| Dried blood spot analysis for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis DH Vu, MS Bolhuis, RA Koster, B Greijdanus, WCM De Lange, ... Antimicrobial agents and chemotherapy 56 (11), 5758-5763, 2012 | 99 | 2012 |
| Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients MS Bolhuis, R van Altena, D van Soolingen, WCM de Lange, DRA Uges, ... European Respiratory Journal 42 (6), 1614-1621, 2013 | 96 | 2013 |
| Current status and opportunities for therapeutic drug monitoring in the treatment of tuberculosis MA Zuur, MS Bolhuis, R Anthony, A den Hertog, T van der Laan, B Wilffert, ... Expert opinion on drug metabolism & toxicology 12 (5), 509-521, 2016 | 87 | 2016 |
| Incorporating therapeutic drug monitoring into the World Health Organization hierarchy of tuberculosis diagnostics S Ghimire, MS Bolhuis, MGG Sturkenboom, OW Akkerman, ... European Respiratory Journal 47 (6), 1867-1869, 2016 | 82 | 2016 |
| Pharmacokinetic drug interactions of antimicrobial drugs: a systematic review on oxazolidinones, rifamycines, macrolides, fluoroquinolones, and beta-lactams MS Bolhuis, PN Panday, AD Pranger, JGW Kosterink, JWC Alffenaar Pharmaceutics 3 (4), 865-913, 2011 | 79* | 2011 |
| Linezolid-based regimens for multidrug-resistant tuberculosis (TB): a systematic review to establish or revise the current recommended dose for TB treatment MS Bolhuis, OW Akkerman, MGG Sturkenboom, S Ghimire, S Srivastava, ... Clinical Infectious Diseases 67 (suppl_3), S327-S335, 2018 | 77 | 2018 |
| Pharmacokinetics of bedaquiline in cerebrospinal fluid and serum in multidrug-resistant tuberculous meningitis OW Akkerman, OFF Odish, MS Bolhuis, WCM de Lange, HPH Kremer, ... Clinical Infectious Diseases 62 (4), 523-524, 2016 | 66 | 2016 |
| End TB with precision treatment! EPM van der Burgt, MGG Sturkenboom, MS Bolhuis, OW Akkerman, ... European Respiratory Journal 47 (2), 680-682, 2016 | 60 | 2016 |
| Linezolid tolerability in multidrug-resistant tuberculosis: a retrospective study MS Bolhuis, S Tiberi, G Sotgiu, S De Lorenzo, JGW Kosterink, ... European Respiratory Journal 46 (4), 1205-1207, 2015 | 53 | 2015 |
| Systematic review of salivary versus blood concentrations of antituberculosis drugs and their potential for salivary therapeutic drug monitoring SHJ van den Elsen, LM Oostenbrink, SK Heysell, D Hira, DJ Touw, ... Therapeutic drug monitoring 40 (1), 17-37, 2018 | 50 | 2018 |
| Clarithromycin significantly increases linezolid serum concentrations MS Bolhuis, R van Altena, DRA Uges, TS van der Werf, JGW Kosterink, ... Antimicrobial agents and chemotherapy 54 (12), 5418, 2010 | 48 | 2010 |
| Linezolid pharmacokinetics in MDR-TB: a systematic review, meta-analysis and Monte Carlo simulation J Millard, H Pertinez, L Bonnett, EM Hodel, V Dartois, JL Johnson, ... Journal of Antimicrobial Chemotherapy 73 (7), 1755-1762, 2018 | 46 | 2018 |
| Simple strategy to assess linezolid exposure in patients with multi-drug-resistant and extensively-drug-resistant tuberculosis J Kamp, MS Bolhuis, S Tiberi, OW Akkerman, R Centis, WC de Lange, ... International journal of antimicrobial agents 49 (6), 688-694, 2017 | 45 | 2017 |
| Determination of bedaquiline in human serum using liquid chromatography-tandem mass spectrometry JWC Alffenaar, M Bolhuis, K Van Hateren, M Sturkenboom, O Akkerman, ... Antimicrobial agents and chemotherapy 59 (9), 5675-5680, 2015 | 39 | 2015 |
| Clinical validation of the analysis of linezolid and clarithromycin in oral fluid of patients with multidrug-resistant tuberculosis MS Bolhuis, R Van Altena, K Van Hateren, WCM de Lange, B Greijdanus, ... Antimicrobial agents and chemotherapy 57 (8), 3676-3680, 2013 | 37 | 2013 |
| In Vitro Susceptibility of Mycobacterium tuberculosis to Amikacin, Kanamycin, and Capreomycin JA Dijkstra, T Van Der Laan, OW Akkerman, MS Bolhuis, WCM de Lange, ... Antimicrobial Agents and Chemotherapy 62 (3), 10.1128/aac. 01724-17, 2018 | 35 | 2018 |
| Amikacin dosing for MDR tuberculosis: a systematic review to establish or revise the current recommended dose for tuberculosis treatment MGG Sturkenboom, N Simbar, OW Akkerman, S Ghimire, MS Bolhuis, ... Clinical Infectious Diseases 67 (suppl_3), S303-S307, 2018 | 33 | 2018 |
| Clinical standards for drug-susceptible pulmonary TB OW Akkerman, R Duarte, S Tiberi, HS Schaaf, C Lange, JWC Alffenaar, ... The International Journal of Tuberculosis and Lung Disease 26 (7), 592-604, 2022 | 30 | 2022 |
